Log in
grant

Pinal County receives $320K grant for drug to treat opioid narcotic overdoses

Posted

A four-year, $80,000 annual grant will be used to purchase and distribute to Pinal County residents a drug that can treat opioid narcotic overdoses in an emergency situation.

The Pinal County Public Health Services District Board of Directors, comprised of the county board of supervisors, voted 4-0 April 2 to approve the overdose data to action grant for Sept. 1, 2024, to Aug. 31, 2028, between Arizona Department of Health Services and the district through the board of supervisors. Director Mike Goodman was absent.

Prior to the vote, Gold Canyon resident Roberto Reveles asked if recent defunding decisions by the U.S. government would impact the funds received by Pinal County.

“With the recent announcement by President Trump of the pulling of funds, what impact does that have on this grant?” Reveles asked.

Jan Vidimos, a manager with Pinal County Public Health, thanked Reveles for the question and said the funds will be used to purchase Naxolone.

“So this grant works with prevention methods and methods that are considered harm-reduction methods. So what we’re doing right now is we’re getting Naxolone in the hands of as many community members as possible. We know that folks who — whether they’re using paid medication legitimately as their doctor prescribed or they suffer from substance abuse disorder — may end up with a situation were they have taken too much. And Naxolone saves lives,” she said.

“Should the program go away, we do have opioid settlement dollars that are available to the county, which we would apply for obviously to continue the program.” Vidimos said.

Other programs with the Arizona Department of Health Services provide Naxolone to emergency medical services and law-enforcement officials, she said.

Richard H. Dyer can be reached at rdyer@iniusa.org, or on X @rhdyer. To voice your opinion on this story, connect with us at AzOpinions@iniusa.org.

Pinal County, health

Share with others


Have an opinion on this story? Click here to send a letter to our editors.

Comments

No comments on this item Please log in to comment by clicking here